← Back to search
EMORY UNIVERSITY
ATLANTA, GA, 30322
UnclaimedClaim this profile (free)
Other Than Small Business
Prime contracting experience
Showing the 50 most recent of 88 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) - REGIONAL HUBS; BASE PERIOD 09/30/2026 - 09/29/2027 | 75N98026D00098USAspending | $877,336 | Sep 28, 2026 | Sep 30, 2026 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - VALIDATION CENTER | 75N92022D00015USAspending | $18,769,273 | Sep 28, 2026 | Sep 15, 2026 – Sep 14, 2028 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA HOME LAIV STUDY CONTRIBUTING SITE - EO 14398 | 75D30123D18248USAspending | $910,875 | Sep 25, 2026 | Sep 25, 2026 – Sep 27, 2029 |
| Prime | Department of Health and Human Services National Institutes of Health | THE STUDY WILL EXAMINE NOVEL AND LEGACY PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND OTHER EXOGENOUS, PERSISTENT ENVIRONMENTAL CHEMICALS IN THE SISTER STUDY. | — | $768,750 | Sep 25, 2026 | Sep 28, 2026 – Sep 27, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | BIOL SPECIMENS FOR LENACAPAVIR PEP | — | $350,000 | Sep 23, 2026 | Sep 23, 2026 – Sep 21, 2028 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | CORE SERVICES | 36C24E22D0003USAspending | $350,000 | Sep 23, 2026 | Sep 28, 2026 – Sep 27, 2027 |
| Prime | Department of Health and Human Services Food and Drug Administration | EO 14398- BAA STUDY ENTITLED, EVALUATING THE FIT-FOR-PURPOSE OF PATIENT REPORTED OUTCOMES FOR MEDICAL DEVICE EVALUATION AIMS 1-3. | — | $1,149,236 | Sep 18, 2026 | Sep 30, 2026 – Sep 29, 2029 |
| Prime | Department of Health and Human Services National Institutes of Health | NIH TCF TASK ORDER B-3/75N93021F00001 09/07/2021-03/20/2025 EDITED BY BAHRAMIT_NIH ON 09/01/2021 16:59:45 | 75N93020D00005USAspending | $1,056,559 | Sep 16, 2026 | Sep 1, 2021 – Sep 30, 2026 |
| Prime | Department of Transportation National Highway Traffic Safety Administration | EMORY UNIVERSITY CIREN PEDESTRIAN AND MOTOR VEHICLE ENROLLMENT TASK ORDER | 693JJ922D000025USAspending | $4,387,261 | Sep 16, 2026 | Sep 28, 2022 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | NIH TCF BASE YEAR 1 TASK A-1, 03/21/2020-03/20/2021 | 75N93020D00005USAspending | $20,383,102 | Sep 14, 2026 | Mar 19, 2020 – Mar 20, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | 75D30123D18248USAspending | $763,380 | Sep 13, 2026 | Sep 28, 2023 – Sep 27, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SEER - CORE INFRASTRUCTURE | 75N91018D00003USAspending | $26,349,170 | Aug 27, 2026 | May 1, 2018 – Apr 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) | — | $38,420,872 | Aug 27, 2026 | Jan 9, 2014 – Jul 31, 2022 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | MATCHED BIOLOGICAL SPECIMENS - EO 14398 | — | $325,000 | Aug 21, 2026 | Sep 1, 2026 – Jul 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | AWARD OF THE BASE TO EMORY FOR CEIRR CONTRACT 75N93021C00017 | — | $29,833,581 | Aug 13, 2026 | Apr 1, 2021 – Sep 23, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX INNOVATION FUNNEL FOR HEALTH TECHNOLOGIES - VALIDATION CENTER | 75N92022D00015USAspending | $7,913,029 | Aug 5, 2026 | Sep 30, 2024 – Sep 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | COMMON FUND REPLICATION TO ENHANCE RESEARCH IMPACT INITIATIVE ("REPLICATION INITIATIVE") - VALIDATION CENTER | 75N92022D00015USAspending | $4,082,596 | Aug 5, 2026 | Sep 20, 2024 – Aug 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | FUNCTIONAL OMICS CORE LABORATORY | — | $4,192,264 | Jul 14, 2026 | May 15, 2025 – May 14, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | TOPIC 21.2 - COVID19 VACCINE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS IN ATLANTA PUBLIC SCHOOL SYSTEM | — | $591,117 | Jul 1, 2026 | Jul 31, 2022 – Jul 28, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA RSV INFANTS STUDY (CONTRIBUTING SITE) | 75D30123D18248USAspending | $774,481 | Jun 22, 2026 | Sep 27, 2024 – Sep 26, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | COMMUNITY VITAL SIGNS | — | $549,161 | Jun 9, 2026 | Jun 23, 2022 – Sep 12, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | URBAN ECOLOGY AND CONTTOL OF ANOPHELES STEPHENSI IN ETHIOPIA | — | $271,409 | Jun 9, 2026 | Sep 29, 2023 – Sep 28, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | 75D30123D18248USAspending | $966,702 | Jun 9, 2026 | Sep 27, 2023 – Sep 27, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | EMORY EMERGENCY SERVICES | — | $1,829,222 | Jun 9, 2026 | Mar 3, 2026 – Feb 28, 2031 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | TESTING OF INACTIVATED ROTAVIRUS VACCINE (IRV) | — | $530,422 | Jun 9, 2026 | Sep 9, 2020 – Sep 14, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | BAA FY23 TOPIC 33.1 - EMORY UNIVERSITY | — | $1,807,738 | Jun 9, 2026 | Sep 11, 2023 – Sep 10, 2026 |
| Prime | Department of Health and Human Services Health Resources and Services Administration | THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OUTPATIENT HANSEN'S DISEASE SERVICES, WHICH INCLUDES DIAGNOSIS, SCREENING, OUTPATIENT TREATMENT, CASE MANAGEMENT, AND FOLLOW-UP CARE IN HEALTHCARE SETTINGS LOCATED THROUGHOUT THE UNITED STATES. | — | $354,389 | May 28, 2026 | Sep 28, 2023 – Mar 27, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - VALIDATION CENTER | 75N92022D00015USAspending | $6,165,610 | May 12, 2026 | May 28, 2024 – Jan 15, 2028 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | CLINICAL CARDIOTHORACIC | — | $1,258,728 | May 4, 2026 | Mar 2, 2024 – Aug 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | CORE SERVICES | 36C24E22D0003USAspending | $314,920 | Apr 29, 2026 | Nov 1, 2022 – Oct 31, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX INDEPENDENT TEST ASSESSMENT PROGRAM FOR HEPATITIS C VIRUS - VALIDATION CENTER | 75N92022D00015USAspending | $7,560,000 | Mar 10, 2026 | Sep 23, 2022 – Mar 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER | 75N92022D00015USAspending | $41,200,000 | Jan 28, 2026 | Mar 27, 2023 – Mar 26, 2027 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RESEARCH CORE SERVICES | 36C24E22D0003USAspending | $275,000 | Jan 9, 2026 | Jan 9, 2026 – Jan 8, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) INNOVATION FUNNEL FOR MATERNAL HEALTH - VALIDATION CENTER | 75N92022D00015USAspending | $1,799,986 | Dec 18, 2025 | Sep 22, 2022 – Jun 30, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF:: ELASTOMERIC RESPIRATOR STUDY | — | $913,592 | Dec 2, 2025 | Sep 1, 2018 – Aug 31, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | RADX INDEPENDENT TEST ASSESSMENT PROGRAM FOR MPOX LESION PANEL - VALIDATION CENTER | 75N92022D00015USAspending | $2,186,787 | Dec 2, 2025 | Sep 27, 2023 – Dec 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | NEW TO: NEWBORN SCREENING PILOT STUDY FOR AN EXPANDED GROUP OF HOMOCYSTINURIA (HCU)-RELATED DISORDERS (TERMED "EXPANDED HCU") | HHSN275201500001IUSAspending | $783,462 | Sep 10, 2025 | Sep 28, 2020 – Jul 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | TASK AREA B-2; POP 09/14/2020-03/20/2023; DAIT/BIOD CAN 8470039; $599,404.00 | 75N93020D00005USAspending | $599,404 | Sep 4, 2025 | Sep 8, 2020 – Mar 20, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CLINICAL CARE AND MEDICAL DIAGNOSTIC SERVICES | — | $7,614,263 | Aug 29, 2025 | Sep 2, 2020 – Feb 28, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | COMPARISON OF TST VS IGRAS IN LTBI PATIENTS | HHSD200201141278IUSAspending | $4,556,143 | Jul 31, 2025 | Sep 29, 2011 – Sep 28, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | 1300018I EMORY UNIVERSITY; VTEU; TO 75N93020F00001-17-0111.B1C1D1.0126--TASK AREA B-D WOLBACHIA-INFECTED AEDES AEGYPTI MOSQUITOS IN REDUCING ARBOVIRAL INFECTION BRAZIL | HHSN272201300018IUSAspending | $7,999,514 | Jun 12, 2025 | Feb 4, 2020 – Nov 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | VACCINE AND TREATMENT EVALUATION UNITS (VTEU) OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA A-D TASK ORDER FY.2019.A1B1C1D1.0103 | HHSN272201300018IUSAspending | $1,072,783 | Jan 7, 2025 | Jun 19, 2018 – Aug 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | 1300018I EMORY UNIVERSITY; VTEU; FY.2020.A1B1C1D1.0123--18 BASE AWARD; BIOD CAN 8470038; $296,087 | HHSN272201300018IUSAspending | $4,216,971 | Jan 7, 2025 | Jul 12, 2019 – Jul 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) INNOVATION FUNNEL VALIDATION CENTER FOR RADX INDEPENDENT TEST ASSESSMENT PROGRAM FOR MONKEYPOX - VALIDATION CENTER | 75N92022D00015USAspending | $4,680,018 | Nov 25, 2024 | Sep 15, 2022 – Mar 31, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | CORE SERVICES | 36C24E22D0003USAspending | $369,579 | Nov 20, 2024 | Nov 20, 2024 – Nov 19, 2025 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF FOR OTHER FUNCTIONS | — | $412,779 | Sep 27, 2024 | Jul 14, 2014 – Sep 15, 2015 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | HIV RESEARCH | — | $450,000 | Aug 23, 2024 | Sep 30, 2022 – Dec 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF VACCINE TREATMENT AND EVALUATION UNITS (VTEU) | HHSN272201300018IUSAspending | $1,670,223 | Aug 6, 2024 | Jan 3, 2018 – May 31, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | SARS - COV-2 APPLIED RESEARCH FOR NCEZID | — | $622,109 | Jun 21, 2024 | Nov 29, 2020 – Nov 28, 2022 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | DEVELOPMENT OF AN EQUITY TOOLKIT AND DASHBOARD FOR MATERNAL MORTALITY REVIEW COMMITTEE | — | $919,147 | Jun 18, 2024 | Sep 13, 2019 – Sep 12, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
Showing the 50 most recent of 51 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | LAKDAWALA STATEMENT OF WORK
IN THIS REVISED CEIRR SUBCONTRACT, THE LAKDAWALA LAB AT EMORY UNIVERSITY WILL LEVERAGE
OUR INFLUENZA TRANSMISSION AND PATHOGENESIS EXPERTISE TO ASSIST IN MULTIPLE PROJECTS. WE
USE OUR EXTENSIVE KNOWLEDGE OF VIRAL PROPERTIES THAT PROMOTE AIRBORNE TRANSMISSION OF
INFLUENZA VIRUSES TO CHARACTERIZE EMERGING ZOONOTIC STRAINS EACH YEAR. OUR SPECIFIC
STATEMENT OF WORK FOR EACH ELEMENT OF THE CEIRR APPLICATION IS DETAILED BELOW.
REQUIRED #3: INFLUENZA SURVEILLANCE, RISK ASSESSMENT AND RESPONSE
TASKS:
1. ASSESS THE REPLICATION OF EMERGING SWINE AND AVIAN VIRUSES IN PRIMARY HUMAN
BRONCHIAL EPITHELIAL CELLS.
2. ASSIST IN MOLECULAR CHARACTERIZATION OF EMERGING SWINE AND AVIAN VIRUSES.
REQUIRED #4: PRE-PANDEMIC AND PANDEMIC RESPONSE
TASKS:
1. PERFORM FERRET PATHOGENESIS STUDIES FOR 1-3 INFLUENZA VIRUSES PER YEAR. (UP TO 12
ANIMALS PER YEAR)
2. PERFORM FERRET AIRBORNE TRANSMISSION STUDIES IN NAÏVE ANIMALS FOR 1-3 VIRUSES PER
YEAR. (24 ANIMALS PER YEAR)
3. ASSESS TRANSMISSIBILITY OF EMERGING VIRUSES IN FERRETS WITH PRE-EXISTING IMMUNITY.
(16 ANIMALS PER YEAR)
4. PERFORM MOLECULAR CHARACTERIZATION OF THESE VIRUSES TO ASSESS GROWTH IN PRIMARY
HUMAN AIRWAY CELLS, STABILITY IN SIMULATED EXPELLED DROPLETS, RECEPTOR AND CELL
TROPISM, AND NA ACTIVITY.
REQUIRED #5: PATHOGENESIS AND IMMUNE RESPONSE RESEARCH (PROJECT 2: IMMUNITY
CHANGING OVER TIME).
TASKS:
1. PERFORM FERRET STUDIES TO ASSESS IMMUNE RESPONSES TO VACCINATION IN THE CONTEXT
OF PRE-EXISTING IMMUNITY. (8 ANIMALS PER YEAR)
2. PERFORM FERRET STUDIES TO DEFINE THE LONGEVITY OF ANTIBODY RESPONSES IN THE FERRET
MODEL (4 ANIMALS PER YEAR) 504429 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: PA Parent award description: AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) View parent award on USAspending | — | $363,650 | Apr 1, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE. 21597- KB 10079 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541990 Parent award performance state: MD Parent award description: CHOICE PLUS STUDY View parent award on USAspending | — | -$180,348 | Jan 23, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | PIVOTAL CLINICAL STUDY BFDF CSA #055 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: UT Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING COV PANEL AS A NUCLEIC ACID AMPLIFICATION TEST PANEL FOR USE ON THE EASY-TO-USE FILMARRAY 2.0 AND FILMARRAY TORCH PLATFORMS. View parent award on USAspending | — | $232,825 | Oct 3, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. 000542103-T002-SC003-WOR-A09 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $406,595 | Aug 22, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | THE SUTHAR LABORATORY WILL COMPLETE THE SARS-COV-2 MOUSE CHALLENGE AND LIVE VIRUS NEUTRALIZATION ASSAYS TO COMPARE RESPONSES ACROSS ADJUVANTED VACCINE DATASETS AS DESCRIBED IN THE CONTRACT PROPOSAL. 63006063-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $227,491 | Aug 15, 2025 | — – — |
| Subcontractor | Department of Energy | EMORY UNIVERSITY-STAND ALONE-ITEM LEVEL-R AND D CW96538 Parent award context Parent award agency: Department of Energy · Department of Energy Parent award NAICS: 561210 Parent award performance state: NM Parent award description: IGF::CL::IGF COMPETITION FOR MANAGEMENT AND OPERATION OF LOS ALAMOS NATIONAL LABORATORY View parent award on USAspending | — | $350,000 | Jun 10, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | PILOT CLINICAL STUDY BFDF CSA #049 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: UT Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING COV PANEL AS A NUCLEIC ACID AMPLIFICATION TEST PANEL FOR USE ON THE EASY-TO-USE FILMARRAY 2.0 AND FILMARRAY TORCH PLATFORMS. View parent award on USAspending | — | $121,192 | Jun 5, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | ALL WORK WILL BE PERFORMED AT GEORGIA TECH IN SUPPORT OF ATTACHMENT I - STATEMENT OF WORK FOR PROJECT: SKIN PATCH TO COLLECT INTERSTITIAL FLUID FOR MULTIPLEXED BIO-SENSING. THIS IS THE PAYMENT MECHANISM THAT THE GEORGIA TECH DEPARTMENT OF BIOMEDICAL ENGINEERING HAS SET UP TO PAY GRADUATE STUDENTS REGISTERED AT EMORY AND WORKING AT GEORGIA TECH.
THIS SUBCONTRACT IS TO PAY A GRADUATE STUDENT WORKING IN THE PRAUSNITZ LAB AT GEORGIA TECH. ISAREE PITAKTONG IS UNIQUELY QUALIFIED TO MEET THE ABOVE REQUIREMENTS. BECAUSE THE STUDENT IS A MD/PHD STUDENT AT EMORY, WE NEED TO PAY HER THROUGH THE EMORY HR SYSTEM NOT THROUGH THE GEORGIA TECH HR SYSTEM. THEREFORE, EMORY IS THE ONLY INSTITUTION THAT CAN RECEIVE THIS SUBCONTRACT TO PAY THE STUDENT. AWD-006343-S1 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: GA Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A USER-FRIENDLY, POINT-OF-CARE MICRONEEDLE PATCH THAT RAPIDLY COLLECTS DERMAL INTERSTITIAL FLUID (ISF) FROM SKIN AND EMPLOYS MULTIPLEXED BIOSENSORS FOR SIMULTANEOUS MEASUREMENT OF BIOMARKERS. View parent award on USAspending | — | $89,327 | May 1, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | LAKDAWALA STATEMENT OF WORK
IN THIS REVISED CEIRR SUBCONTRACT, THE LAKDAWALA LAB AT EMORY UNIVERSITY WILL LEVERAGE
OUR INFLUENZA TRANSMISSION AND PATHOGENESIS EXPERTISE TO ASSIST IN MULTIPLE PROJECTS. WE
USE OUR EXTENSIVE KNOWLEDGE OF VIRAL PROPERTIES THAT PROMOTE AIRBORNE TRANSMISSION OF
INFLUENZA VIRUSES TO CHARACTERIZE EMERGING ZOONOTIC STRAINS EACH YEAR. OUR SPECIFIC
STATEMENT OF WORK FOR EACH ELEMENT OF THE CEIRR APPLICATION IS DETAILED BELOW.
REQUIRED #3: INFLUENZA SURVEILLANCE, RISK ASSESSMENT AND RESPONSE
TASKS:
1. ASSESS THE REPLICATION OF EMERGING SWINE AND AVIAN VIRUSES IN PRIMARY HUMAN
BRONCHIAL EPITHELIAL CELLS.
2. ASSIST IN MOLECULAR CHARACTERIZATION OF EMERGING SWINE AND AVIAN VIRUSES.
REQUIRED #4: PRE-PANDEMIC AND PANDEMIC RESPONSE
TASKS:
1. PERFORM FERRET PATHOGENESIS STUDIES FOR 1-3 INFLUENZA VIRUSES PER YEAR. (UP TO 12
ANIMALS PER YEAR)
2. PERFORM FERRET AIRBORNE TRANSMISSION STUDIES IN NAÏVE ANIMALS FOR 1-3 VIRUSES PER
YEAR. (24 ANIMALS PER YEAR)
3. ASSESS TRANSMISSIBILITY OF EMERGING VIRUSES IN FERRETS WITH PRE-EXISTING IMMUNITY.
(16 ANIMALS PER YEAR)
4. PERFORM MOLECULAR CHARACTERIZATION OF THESE VIRUSES TO ASSESS GROWTH IN PRIMARY
HUMAN AIRWAY CELLS, STABILITY IN SIMULATED EXPELLED DROPLETS, RECEPTOR AND CELL
TROPISM, AND NA ACTIVITY.
REQUIRED #5: PATHOGENESIS AND IMMUNE RESPONSE RESEARCH (PROJECT 2: IMMUNITY
CHANGING OVER TIME).
TASKS:
1. PERFORM FERRET STUDIES TO ASSESS IMMUNE RESPONSES TO VACCINATION IN THE CONTEXT
OF PRE-EXISTING IMMUNITY. (8 ANIMALS PER YEAR)
2. PERFORM FERRET STUDIES TO DEFINE THE LONGEVITY OF ANTIBODY RESPONSES IN THE FERRET
MODEL (4 ANIMALS PER YEAR) 502355 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: PA Parent award description: AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR) View parent award on USAspending | — | $354,507 | Apr 22, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. 000542103-T002-SC003-WOR-A08 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $190,274 | Dec 11, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE) 21597-KB 7363 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541990 Parent award performance state: MD Parent award description: CHOICE PLUS STUDY View parent award on USAspending | — | $752,515 | Nov 20, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | DR. TIROUVANZIAM AND HIS LABORATORY AT EMORY UNIVERSITY COMMITS TO PROVIDING SUPPORT FOR THE FDA GRANT DIRECTED BY DR. SHUICHI TAKAYAMA (THE GEORGIA INSTITUTE OF TECHNOLOGY AND EMORY UNIVERISTY, ATLANTA, GEORGIA, USA), ENTITLED: €œIN VITRO ASSESSMENT OF CHEMICAL MIXTURE- INDUCED AIRWAY INFLAMMAAON IN HEALTHY AND DISEASED LUNGS€Ͽ½.
THIS PROJECT WILL USE A HIGH-THROUGHPUT IN VITRO AIR-BLOOD BARRIER ARRAY BASED BARRIER BREAKDOWN AND NEUTROPHIL TRANSMIGRATION/ACTIVATION ASSAY TO PREDICT HUMAN ADVERSE REACTIONS TO INHALED SUBSTANCES. DOSE RESPONSE CURVES AND BENCHMARK DOSES (BMD) WILL BE DETERMINED FOR A RANGE OF WELL-KNOWN AND UNKNOWN SUBSTANCES INCLUDING ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS) CONSTITUENTS AND MIXTURES. INITIAL YEARS WILL FOCUS ON HIGH-THROUGHPUT E-CIGARETTE VAPOR EXTRACTS (EVE) ANALYSIS, LATER YEARS WILL ALSO ANALYZE E-CIGARETTE AEROSOL DIRECTLY IN A LOWER-THROUGHPUT FORMAT. THE ORGAN-LEVEL FUNCTIONAL READOUTS (TEER & TRANSMIGRATION) RELATE CLOSELY TO CLINICAL/PRE-CLINICAL BRONCHOALVEOLAR LAVAGE (BAL) MEASURES, ARE CONVENIENT IN CONSISTING OF JUST A FEW KEY NUMBERS, YET ARE INTEGRATIVE OF MULTIPLE MOLECULAR AND CELLULAR PATHWAYS AND THUS HIGHLY PHYSIOLOGICALLY-RELEVANT. THIS PROJECT WILL ANALYZE THE EFFECT OF BIOLOGICALLY VARIABILITY WITH REGARDS TO THE SEX OF THE PRIMARY HUMAN NEUTROPHILS AND EPITHELIAL CELLS. THE PROJECT WILL ALSO ANALYZE THE IMPACT VAPING PLUS OTHER LUNG INSULTS CAN HAVE WHEN COMBINED TOGETHER BY TESTING EVES IN COMBINATION WITH DEFINED INFLAMMATORY COCKTAILS REFERRED TO AS SYNTHETIC AIRWAY FLUID SUPERNATANT (SASN) (EARLY YEARS) OR COPD ASN (LATER YEARS).
SUPPORT PROVIDED BY THE TIROUVANZIAM LAB AT ERMORY WILL BE IN THE FORM OF: (I) SUPPORT FOR THE DEVELOPMENT OF THE PRIMARY MODEL; (II) PERFORMANCE OF PHENOTYPIC AND FUNCTIONAL ASSAYS; (III) SUPPORT FOR DATA ANALYSIS AND INTEGRATION; AND (IV) REPORTING OF RESULTS AND CONTRIBUTION TO SCIENTIFIC ABSTRACTS AND MANUSCRIPTS.
THE TIROUVANZIAM LAB IS PARTICULARLY WELL EQUIPPED FOR SUCH STUDIES AND HAS UNIQUE EXPERTISE IN THE IMPLEMENTATION OF IN VITRO ASSAYS RELATED TO AIRWAY NEUTROPHLIC INFLAMMATION, AS EVIDENCED BY PRIOR PUBLICATIONS RELEVANT TO THIS TOPIC. TO ENSURE PROPER IMPLEMENTATION OF THE EXTENSIVE WORK INCLUDED IN THIS STATEMENT, DR. TIROUVANZIAM WILL COMMIT 10% OF HIS EFFORT, 10% OF EFFORT FOR A POSTDOCTORAL BIOINFORMATICIAN AND 20% FOR A RESEARCH SPECIALIST SUPERVISOR IN EACH OF YRS 1-3 OF THIS PROJECT. AWD-004704-S2 Parent award context Parent award agency: Department of Health and Human Services · Food and Drug Administration Parent award NAICS: 541714 Parent award performance state: MD Parent award description: BAA TOXWP 118/CTP-2022-112800 -EVALUATE AND PROMOTE THE USE OF CELL- AND TISSUE-BASED ASSAYS THAT MORE ACCURATELY REPRESENT HUMAN SUSCEPTIBILITY THAN ANIMAL MODELS TO ADVERSE REACTIONS AND PREDICT THRESHOLD OF TOXICOLOGICAL CONCERNS RESULTING FROM EX View parent award on USAspending | — | $360,356 | Nov 6, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. 000542103-T002-SC003-WOR-A07 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $217,221 | Oct 14, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY UNIVERSITY WILL ASSIST THE CDC WITH ESTABLISHING A PLATFORM THAT INVOLVES A NETWORK OF NURSING HOMES WITH PRE-POSITIONED STUDY STAFF AND READILY AVAILABLE LABORATORY CAPACITY TO PERFORM DATA COLLECTION WITHOUT IMPACTING CLINICAL CARE TO RAPIDLY CHARACTERIZE INFECTIOUS DISEASES, PARTICULARLY EMERGING PATHOGENS AND SARS-COV-2 VARIANTS OF CONCERN, TO INFORM INFECTION PREVENTION AND CONTROL STRATEGIES IN NURSING HOMES. 54229 MOD 002 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541990 Parent award performance state: MD Parent award description: 2022 D1-A009 NURSING HOME PUBLIC HEALTH RESPONSE NETWORK View parent award on USAspending | 75D30121D12704USAspending | $496,690 | Sep 30, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFEÂÂTHREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES
(OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT (EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE CLINICAL TRIAL). AWD00008169-15 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $231,111 | Sep 27, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFEÂÂTHREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES
(OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT (EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE CLINICAL TRIAL). AWD00008169-15 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $231,111 | Sep 27, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105649 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $535,000 | Aug 12, 2024 | — – — |
| Subcontractor | Department of Defense | ENGINEERING SERVICES IN SUPPORT OF THE PRIME RSC24016 Parent award context Parent award agency: Department of Defense · Department of the Air Force Parent award NAICS: 541715 Parent award performance state: OH Parent award description: CLASSICAL-QUANTUM HYBRID CONSTRUCTS TO ADVANCE WEAPONS SYSTEMS View parent award on USAspending | FA865120D0003USAspending | $690,000 | Jul 8, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE) 21597-KB 5605 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541990 Parent award performance state: MD Parent award description: CHOICE PLUS STUDY View parent award on USAspending | — | $752,515 | May 29, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THIS STUDY WILL UTILIZE SYSTEMS IMMUNOLOGY APPROACHES TO INVESTIGATE THE IMMUNE SIGNATURES GENERATED BY OUR SARNA YFV VACCINE AND COMPARE THESE TO THE GOLD STANDARD YFV-17D LIVE-ATTENUATED VACCINE (YF-VAX). IMMUNE SIGNATURES WILL BE OBTAINED BY TRANSCRIPTOMIC ANALYSIS FOLLOWING PRIME AND BOOST IMMUNIZATIONS AND WILL CAPTURE BOTH EARLY INNATE AND ADAPTIVE IMMUNE SIGNATURES. IN ADDITION, WE WILL INVESTIGATE THE ANTIBODY REPERTOIRE GENERATED BY OUR VACCINE PLATFORM. WE WILL CORRELATE THESE SIGNATURES TO RESPONSE MEASURES OF CELLULAR AND HUMORAL IMMUNITY. CELLULAR IMMUNITY WILL FOCUS ON MARKERS OF MEMORY DEPOSITION FOR B CELLS (E.G., CD27) AND T CELLS AS A PRELIMINARY INDICATOR OF RESPONSE DURABILITY AND LONGEVITY. 75N93019C00059-NV1190-OP1C-EMORY Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: WA Parent award description: TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 View parent award on USAspending | — | $1,226,960 | May 7, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE SUTHAR LABORATORY WILL COMPLETE THE SARS-COV-2 MOUSE CHALLENGE AND LIVE VIRUS NEUTRALIZATION ASSAYS TO COMPARE RESPONSES ACROSS ADJUVANTED VACCINE DATASETS AS DESCRIBED IN THE CONTRACT PROPOSAL. 63006063-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $373,100 | Apr 18, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. 000542103-T002-SC003-WOR-A06 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $456,612 | Apr 10, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | R&D K004171-00-S01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: NY Parent award description: TOPIC 426: ATLASCOPE: COMPOSABLE VISUALIZATION TOOLS FOR MULTISCALE INTEGRATIVE BIOLOGY View parent award on USAspending | — | $250,000 | Apr 4, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | OPTION 2: 0258-C504-4609
OPTION 3: 0258-D504-4609
OPTION 4: IF300302118-940002
OPTION 5: IF300302188-940002
THE WORK PERFORMED BY DR. MEDINA AND HIS COLLABORATORS WILL INCLUDE:
1. SURVEILLANCE OF HUMAN INFLUENZA VIRUS IN THE METROPOLITAN AREA OF SANTIAGO.
2. ENROLMENT OF HUMAN SUBJECTS UNDER AN APPROVED IRB PROTOCOL ALLOWING THE COLLECTION OF INFLUENZA CLINICAL SAMPLES AND METADATA.
3. COLLECTION OF 250 INFLUENZA CLINICAL SAMPLES FOR VIRUS ISOLATION AND TO ANALYZE IMMUNE RESPONSES.
4. ESTABLISHING A CLINICAL SAMPLE DATABASE.
5. CHARACTERIZATION (SUBTYPING) OF VIRAL STRAINS AND HOST IMMUNE RESPONSES DURING ACUTE INFECTION FROM 250 VIRAL SAMPLES OBTAINED FROM INDIVIDUALS.
6. SUBMITTING BI-MONTHLY, SEMI-ANNUAL AND ANNUAL CLINICAL PROGRESS REPORTS.
7. SURVEILLANCE OF SWINE INFLUENZA VIRUSES IN THE CENTRAL REGIONS OF CHILE.
8. CHARACTERIZATION OF SWINE VIRAL STRAINS AND GENOTYPES.
9. PERFORMING ANTIGENIC CHARACTERIZATION OF SELECTED ANIMAL STRAINS.
10. COLLABORATING AND EXCHANGING RESEARCH MATERIALS WITH MEMBERS OF THE CENTER.
11. ATTENDING THE CEIRS NETWORK ANNUAL MEETING.
12. ATTENDING SCIENTIFIC ADVISORY BOARD MEETINGS AND CLINICAL SITE VISITS. 0258-C504-4609 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: NY Parent award description: MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE. View parent award on USAspending | — | $869,557 | Mar 18, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105649 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $565,000 | Dec 19, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | MS7-CHRCT & CNFRM TESTING 23X047F1 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $797,266 | Nov 30, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | MS1 DMID COVAIL OVERARCH 22X120F Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS View parent award on USAspending | 75N91019D00024USAspending | $1,553,579 | Nov 15, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY UNIVERSITY WILL ASSIST THE CDC WITH ESTABLISHING A PLATFORM THAT INVOLVES A NETWORK OF NURSING HOMES WITH PRE-POSITIONED STUDY STAFF AND READILY AVAILABLE LABORATORY CAPACITY TO PERFORM DATA COLLECTION WITHOUT IMPACTING CLINICAL CARE TO RAPIDLY CHARACTERIZE INFECTIOUS DISEASES, PARTICULARLY EMERGING PATHOGENS AND SARS-COV-2 VARIANTS OF CONCERN, TO INFORM INFECTION PREVENTION AND CONTROL STRATEGIES IN NURSING HOMES. 54229 (MOD 001) Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541990 Parent award performance state: MD Parent award description: 2022 D1-A009 NURSING HOME PUBLIC HEALTH RESPONSE NETWORK View parent award on USAspending | 75D30121D12704USAspending | $485,337 | Sep 30, 2023 | — – — |
| Subcontractor | Department of Defense | THE CONTRACTOR HAS UNDERTAKEN CERTAIN EFFORTS FOR THE UNITED STATES DEPARTMENT OF DEFENSE. D9969-S1 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541715 Parent award performance state: GA Parent award description: BIOINTELLIGENCE AND BIOSECURITY FOR INTELLIGENCE COMMUNITY (B24IC)RAPID AUTOMATED BIOSOURCING THROUGH MACHINE LEARNING (RABML) View parent award on USAspending | — | $55,184 | Aug 10, 2023 | — – — |
| Subcontractor | Department of Defense | FUNDAMENTAL RESEARCH. SC2207701 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541715 Parent award performance state: MA Parent award description: DARPA BAA HR001122S0032, RESEARCH IAW SOW - BASE View parent award on USAspending | — | $508,514 | Jun 28, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. 000524050-T010-SC003-WOR-A04 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $199,779 | Jun 20, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | RESEARCH K003823-00-S01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: NY Parent award description: TOPIC 411 CONTRACT TITLE: IMAGEDEPHI: IMAGE DE-IDENTIFICATION FOR THE ACCELERATION OF CANCER RESEARCH View parent award on USAspending | — | $250,000 | May 11, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THE SUTHAR LABORATORY WILL COMPLETE THE SARS-COV-2 MOUSE CHALLENGE AND LIVE VIRUS NEUTRALIZATION ASSAYS TO COMPARE RESPONSES ACROSS ADJUVANTED VACCINE DATASETS AS DESCRIBED IN THE CONTRACT PROPOSAL. 63006063-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $373,098 | Feb 25, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN THE DEVELOPMENT OF THE PROTOCOL AND INFORMED CONSENT TEMPLATE. PERFORM ALL CLINICAL STUDY PROCEDURES AS DESCRIBED IN THE PROTOCOL. MANAGE CLINICAL SITE. RECRUIT AND RETAIN STUDY POPULATION. IDENTIFY ANY POTENTIAL PROBLEMS IN CONDUCTING THE CLINICAL TRIAL. MAINTAIN A SYSTEM OF RECORDS. SC003-WOR-A03 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $149,903 | Feb 21, 2023 | — – — |
| Subcontractor | Department of Defense | FUNDAMENTAL RESEARCH SC2207701 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541715 Parent award performance state: MA Parent award description: DARPA BAA HR001122S0032, RESEARCH IAW SOW - BASE View parent award on USAspending | — | $499,341 | Feb 1, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105659 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $580,000 | Dec 13, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY UNIVERSITY WILL BE RESPONSIBLE TO ENROLL AND CONDUCT FOLLOW-UP OF STUDY PARTICIPANTS WITH SYPHILIS WHO MEET THE STUDY ELIGIBILITY CRITERIA FOR THE PURPOSES OF DATA AND SPECIMEN COLLECTION; COLLECT AND ENTER DEMOGRAPHIC, CLINICAL AND LABORATORY DATA. 5132342 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: NC Parent award description: SYPHILIS SPECIMEN COLLECTION View parent award on USAspending | — | $212,955 | Dec 12, 2022 | — – — |
| Subcontractor | Department of Defense | THE CONTRACTOR HAS UNDERTAKEN CERTAIN EFFORTS FOR THE UNITED STATES DEPARTMENT OF DEFENSE. D9849-S2 Parent award context Parent award agency: Department of Defense · Department of the Navy Parent award NAICS: 541715 Parent award performance state: GA Parent award description: DARPA DIGET PROGRAM - TACTICAL RAPID PATHOGEN IDENTIFICATION AND DIAGNOSTIC ENSEMBLE (TRIAGE) View parent award on USAspending | — | $910,081 | Nov 22, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | TA02 TO9 DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING NEISSERIA GONORRHOESE INFECTION 000524050-T010-003 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541711 Parent award performance state: AL Parent award description: THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. View parent award on USAspending | HHSN272201300012IUSAspending | $863,508 | Nov 8, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THIS WILL BE AN EXPANDED ACTIVITY OF THE RVTN PROJECT TO CULTURE VIRUSES FROM SPECIMENS COLLECTED FROM STUDY PARTICIPANTS. VIRAL CULTURES WILL BE CONDUCTED AT EMORY UNIVERSITY BY DR. MEHUL SUTAR 105856 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: GA Parent award description: CONTRACT UNDER FY 21 BROUD AGENCY ANNOUNCEMENT TOPIC 9.3 - VANDERBILT View parent award on USAspending | — | $274,895 | Oct 21, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | EMORY UNIVERSITY WILL ASSIST THE CDC WITH ESTABLISHING A PLATFORM THAT INVOLVES A NETWORK OF NURSING HOMES WITH PRE-POSITIONED STUDY STAFF AND READILY AVAILABLE LABORATORY CAPACITY TO PERFORM DATA COLLECTION WITHOUT IMPACTING CLINICAL CARE TO RAPIDLY CHARACTERIZE INFECTIOUS DISEASES, PARTICULARLY EMERGING PATHOGENS AND SARS-COV-2 VARIANTS OF CONCERN, TO INFORM INFECTION PREVENTION AND CONTROL STRATEGIES IN NURSING HOMES. 54229 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541990 Parent award performance state: MD Parent award description: 2022 D1-A009 NURSING HOME PUBLIC HEALTH RESPONSE NETWORK View parent award on USAspending | 75D30121D12704USAspending | $355,536 | Sep 30, 2022 | — – — |
| Subcontractor | Department of Defense | PREHOSPITAL AIRWAY CONTROL IN TRAUMA (PACT) TRIAL, A 5-YEAR (4-YEAR ENROLLMENT), OPEN LABEL, MULTI-CENTER, STEPPED WEDGE CLUSTER RANDOMIZED TRIAL COMPARING STANDARD STRATEGY AND A STRATEGY OF INITIAL USE OF SGA FOR THE AIRWAY MANAGEMENT OF PREHOSPITAL TRAUMA PATIENTS. THE TRIAL WILL BE CARRIED OUT AT SITES WITHIN THE LITES NETWORK. THE LITES NETWORK IS AN OPERATIONAL TRAUMA CENTER CONSORTIUM WITH THE EXPERTISE, TRACK RECORD, AND CONFIRMED CAPABILITIES TO CONDUCT PROSPECTIVE, MULTICENTER, INJURY CARE AND OUTCOMES RESEARCH RELEVANT TO THE DEPARTMENT OF DEFENSE. THE TRIAL WILL BE CONDUCTED OVER 48 MONTHS WITH APPROXIMATELY 20 PREHOSPITAL AGENCIES CROSSING FROM CONTROL ARM TO
INTERVENTION ARM EVERY 6 MONTHS UNTIL MONTH 42, WHEN ALL PREHOSPITAL AGENCIES WILL BE EXPOSED TO THE INTERVENTION
ARM. 0061688-8 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD View parent award on USAspending | W81XWH16D0024USAspending | $539,050 | May 10, 2022 | — – — |
| Subcontractor | Department of Defense | PREHOSPITAL AIRWAY CONTROL IN TRAUMA (PACT) TRIAL, A 5-YEAR (4-YEAR ENROLLMENT), OPEN LABEL, MULTI-CENTER, STEPPED WEDGE CLUSTER RANDOMIZED TRIAL COMPARING STANDARD STRATEGY AND A STRATEGY OF INITIAL USE OF SGA FOR THE AIRWAY MANAGEMENT OF PREHOSPITAL TRAUMA PATIENTS. THE TRIAL WILL BE CARRIED OUT AT SITES WITHIN THE LITES NETWORK. THE LITES NETWORK IS AN OPERATIONAL TRAUMA CENTER CONSORTIUM WITH THE EXPERTISE, TRACK RECORD, AND CONFIRMED CAPABILITIES TO CONDUCT PROSPECTIVE, MULTICENTER, INJURY CARE AND OUTCOMES RESEARCH RELEVANT TO THE DEPARTMENT OF DEFENSE. THE TRIAL WILL BE CONDUCTED OVER 48 MONTHS WITH APPROXIMATELY 20 PREHOSPITAL AGENCIES CROSSING FROM CONTROL ARM TO
INTERVENTION ARM EVERY 6 MONTHS UNTIL MONTH 42, WHEN ALL PREHOSPITAL AGENCIES WILL BE EXPOSED TO THE INTERVENTION
ARM. 0061688-8 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD View parent award on USAspending | W81XWH16D0024USAspending | $539,050 | May 10, 2022 | — – — |
| Subcontractor | Department of Defense | PREHOSPITAL AIRWAY CONTROL IN TRAUMA (PACT) TRIAL, A 5-YEAR (4-YEAR ENROLLMENT), OPEN LABEL, MULTI-CENTER, STEPPED WEDGE CLUSTER RANDOMIZED TRIAL COMPARING STANDARD STRATEGY AND A STRATEGY OF INITIAL USE OF SGA FOR THE AIRWAY MANAGEMENT OF PREHOSPITAL TRAUMA PATIENTS. THE TRIAL WILL BE CARRIED OUT AT SITES WITHIN THE LITES NETWORK. THE LITES NETWORK IS AN OPERATIONAL TRAUMA CENTER CONSORTIUM WITH THE EXPERTISE, TRACK RECORD, AND CONFIRMED CAPABILITIES TO CONDUCT PROSPECTIVE, MULTICENTER, INJURY CARE AND OUTCOMES RESEARCH RELEVANT TO THE DEPARTMENT OF DEFENSE. THE TRIAL WILL BE CONDUCTED OVER 48 MONTHS WITH APPROXIMATELY 20 PREHOSPITAL AGENCIES CROSSING FROM CONTROL ARM TO
INTERVENTION ARM EVERY 6 MONTHS UNTIL MONTH 42, WHEN ALL PREHOSPITAL AGENCIES WILL BE EXPOSED TO THE INTERVENTION
ARM. 0061688-8 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD View parent award on USAspending | W81XWH16D0024USAspending | $539,050 | May 10, 2022 | — – — |
| Subcontractor | Department of Defense | PREHOSPITAL AIRWAY CONTROL IN TRAUMA (PACT) TRIAL, A 5-YEAR (4-YEAR ENROLLMENT), OPEN LABEL, MULTI-CENTER, STEPPED WEDGE CLUSTER RANDOMIZED TRIAL COMPARING STANDARD STRATEGY AND A STRATEGY OF INITIAL USE OF SGA FOR THE AIRWAY MANAGEMENT OF PREHOSPITAL TRAUMA PATIENTS. THE TRIAL WILL BE CARRIED OUT AT SITES WITHIN THE LITES NETWORK. THE LITES NETWORK IS AN OPERATIONAL TRAUMA CENTER CONSORTIUM WITH THE EXPERTISE, TRACK RECORD, AND CONFIRMED CAPABILITIES TO CONDUCT PROSPECTIVE, MULTICENTER, INJURY CARE AND OUTCOMES RESEARCH RELEVANT TO THE DEPARTMENT OF DEFENSE. THE TRIAL WILL BE CONDUCTED OVER 48 MONTHS WITH APPROXIMATELY 20 PREHOSPITAL AGENCIES CROSSING FROM CONTROL ARM TO
INTERVENTION ARM EVERY 6 MONTHS UNTIL MONTH 42, WHEN ALL PREHOSPITAL AGENCIES WILL BE EXPOSED TO THE INTERVENTION
ARM. 0061688-8 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD View parent award on USAspending | W81XWH16D0024USAspending | $539,050 | May 10, 2022 | — – — |
| Subcontractor | Department of Defense | SITE PI AND COORDINATOR SALARY SUPPORT FOR PATIENT RECRUITMENT AND ENROLLMENT. S-10739-04 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541711 Parent award performance state: WA Parent award description: IGF::CT::IGF INTERVENTIONAL STUDY SUPPORT FOR NIRS View parent award on USAspending | — | $110,673 | Apr 7, 2022 | — – — |
| Subcontractor | Department of Defense | SITE PI AND COORDINATOR SALARY SUPPORT FOR PATIENT RECRUITMENT AND ENROLLMENT. S-10739-04 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541711 Parent award performance state: WA Parent award description: IGF::CT::IGF INTERVENTIONAL STUDY SUPPORT FOR NIRS View parent award on USAspending | — | $110,673 | Apr 7, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | CONDUCT NON-HUMAN PRIMATE STUDIES TO TEST THE IMMUNOGENICITY OF DIFFERENT DOSES AND BIVALENT FORMULATIONS OF SELF-AMPLIFYING/SELF-ADJUVANTING RNA VACCINES (SARNA) AGAINST ZIKA VIRUS AND YELLOW FEVER VIRUS TO JUSTIFY AND INFORM PHASE 1 CLINICAL TRIALS IN HUMANS 75N93019C00059-NV1190-OP1A-EMOR Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: WA Parent award description: TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 View parent award on USAspending | — | $850,381 | Apr 6, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF THIS CONTRACT IS TO EVALUATE THE EFFECTIVENESS OF VACCINES AGAINST COVID-19, INFLUENZA, AND EVENTUALLY, RSV, AMONG U.S. ADULTS WITH SEVERE ACUTE RESPIRATORY ILLNESS. THE PRIMARY AIM IS TO MONITOR EFFECTIVENESS AGAINST COVID-19-ASSOCIATED AND INFLUENZA-ASSOCIATED HOSPITALIZATIONS, INCLUDING EFFECTIVENESS AGAINST EMERGING VARIANTS OF CONCERN AND DURATION OF PROTECTION. THE CONTRACT WILL ALSO CONDUCT RSV SURVEILLANCE AMONG INPATIENTS WITH ARI AND BUILD ON PRIOR EFFORTS TO UNDERSTAND SEVERE ARI, SEVERITY SCORES, SUSCEPTIBILITY TO INFECTION, MECHANISMS OF DISEASE ATTENUATION, AND VACCINE FAILURES.
PROJECT TITLE IVY4 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 97770 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $284,000 | Mar 9, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | R&D K993499-00-S01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: NY Parent award description: SBIR PHASE I - TOPIC 426 - TOOLS AND TECHNOLOGIES FOR VISUALIZING MULTI-SCALE DATA View parent award on USAspending | — | $50,000 | Jan 10, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Veterans AffairsGov-sourced
- Department of TransportationGov-sourced
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.